Drug Database
Back to search

Poland· PL-100110464

Aerrane

A isoflurane product containing isofluranum, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC N01AB06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAerraneATCN01AB06REGISTER NO.PL-100110464PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about isofluranumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Isoflurane is registered in 15 of 19 countries.

Countries holding a registration under ATC N01AB06 (isoflurane), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search isoflurane products by name

Isoflurane · ATC N01AB06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Isofluranum
Manufacturer
Baxter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
N01AB06
ATC class
Isoflurane
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990961610
  • gtin
    05909990961627
  • gtin
    05909990649976
  • gtin
    05909990649969

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

58 interactions on record for isoflurane.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check isoflurane against other medicinesHow interaction checks work

Isoflurane · interactions on record

58 records

  • 3 severe
  • 9 moderate
  • 46 info

Most severe, free to view

  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • EpinephrineR03AA01severe
  • OpiumA07DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Isoflurane in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All isoflurane products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Cedaconda
  • Belgium · Sedaconda
  • Bulgaria · Аеран
  • Cyprus · Isoflurane Piramal Critical Care
  • Czechia · Aerrane
  • Germany · Isofluran Baxter, Isofluran-Piramal
  • Denmark · Isofluran Baxter, Sedaconda
  • Spain · Aerrane, Sedaconda
  • Finland · Isofluran Baxter
  • France · Aerrane, Cedaconda
  • United Kingdom (Northern Ireland) · Aerrane, Isoflurane Piramal Critical Care
  • Croatia · Sedaconda
  • Hungary · Aerrane
  • Italy · Aerrane, Sedaconda
  • Malta · Isoflurane Piramal
  • Netherlands · Sedaconda
  • Norway · Isofluran Baxter, Sedaconda
  • Romania · Aerrane, Anesteran
  • Sweden · Isofluran Baxter, Sedaconda
  • Slovenia · Sedaconda
  • Slovakia · Isofluran Piramal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd7ed215-feb5-4d1c-8206-c4362867a8aa
GET /v1/drugs/dd7ed215-feb5-4d1c-8206-c4362867a8aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Płyn do anestezji wziewnej",
  "source": "urpl",
  "strength": "100%",
  "packaging": "05909990961610 ¦ Lz ¦ 19727\n1 butelka 100 ml\n05909990961627 ¦ Lz ¦ 19728\n1 butelka 250 ml\n05909990649976 ¦ Lz ¦ 43984\n6 butelek 250 ml\n05909990649969 ¦ Lz ¦ 46847\n6 butelek 100 ml",
  "substance": "Isofluranum 100 %",
  "common_name": "Isofluranum",
  "pl_product_id": "100110464",
  "pozwolenie_nr": "09616",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about isoflurane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console